ABOUT THE SUMMIT
INNOVATIONS FROM ASIA,
FOR THE WORLD
The APEC Health and Life Sciences Summit 2024 will build on its strong start in 2023 and gather policy makers, industry leaders, development partners, investors and innovators from the health and life sciences ecosystem in Asia Pacific to advance innovation and collaboration in Asia for the world.
Summit Highlights
A Gathering of Health and Life Sciences Leaders in Asia Pacific
150+ leaders and senior executives from 10 over countries in Asia Pacific will gather for the 2.5 day programme.
A Multi-Sectoral Approach to Health & Life Sciences Innovation
Wide-ranging topics that span the entire value chain from APAC regional market trends and opportunities, innovation & regulatory collaborations, to health financing and investing trends in the health and life sciences sector.
Special session on Climate Change and Health, a highly complex issue with widespread impact on the entire industry.
A Platform to Foster Partnership, Innovation and Market Access
A confluence of participants from governments, international organizations, industry associations, financial institutions,academic institutions, and medical institutions, patient groups who are key components for improving access.
Value for Participants
Insights Gathering
Listen to leading public and private sector experts’ experience and opinions in the development of health and life science industry in Asia.
Regional Network Enhancement
Connect with senior executives from the industry, development partners, policy makers in the health and life sciences industry across Asia.
Partnership Formation
Leverage informal networking opportunities to engage with organisations across the industry to find new potential partners.
Highlights from 2023 APAC Health and Life Sciences Summit
The two-day summit covered the landscape of Asia’s life sciences innovation and strategic market opportunities through eight different topics that brought together health system leaders, multi-lateral organization representatives, policy experts, academic leaders, and ecosystem partners from nearly twenty countries and regions in APEC.
80+
Guest speakers
10+
Asian Countries
160+
Industry leaders
(invited only)
The Summit is organised by ASK Health Asia, an international think tank and consulting firm dedicated to health systems transformation in Asia. Over the last seven years, ASK Health Asia has published over 50 reports covering wide ranging topics from health financing, successful ageing, digital health, and climate change and human health and organised over 20 convening events and platforms annually in Asia. These reports and events reached many policy makers and industry leaders, catalysing changes in the health systems and giving people greater access to quality care.
To find out more, visit www.askhealthasia.com
Programme
2024 APAC Health And Life Science Summit
Singapore, Day 1 - 11 November, 2024
TOPIC
CONTENT
Topic 1: The APAC Growth Story
  • APAC market growth trends, trajectory & opportunities 

  • Changes in policies and their impact on industry development and innovation 

  • Cross-sectoral partnerships to create a thriving life science industry in APAC 

Topic 2: APAC Life Science Innovation Landscape
  • Showcase: Innovative solutions by Asia life sciences leaders

  • Leaders insights: Fireside chat with policy & regulatory leaders on cultivating a conducive environment for innovation and successful commercialisation in APAC


Topic 3: Creating a Vibrant Life Science Market
  • Life sciences ecosystem showcase: the CXOs supporting scale up in the region

  • Driving cost-effective innovations for the region through partnerships

  • Innovative financing and improved market access


Topic 4: Asia Life Sciences Investor Forum
  • Growing the next generation champions in APAC, from local innovation to global success 

  • Investment trends in the life sciences sector 

Singapore Night: Invitation-Only, closed-door networking dinner, with speakers and sponsors (30 - 50)
2024 APAC Health And Life Science Summit
Singapore, Day 2 - 12 November, 2024
Special Session: Creating a Climate-Resilient Health Future for Asia
PANEL
CONTENT
Panel 1: The Impact of Climate Change on Health, Calling for Industry Action
  • Overview of climate change effects on population health and health systems 

  • Development partners'strategy on climate change and health, as well as current engagement of industry in climate change and health 

Panel 2: Decarbonizing the Healthcare Sector in Asia
  • Current carbon footprint of the health sector

  • Strategies for reducing emissions, examples from leading companies

Case Study Presentations: Innovations and Collaboration on the Intersection of Climate Change and He
  • Successful collaborative projects/innovative products and solutions

  • Lessons learned, best practices and scale-up approach



Panel 3: Building More Climate-Resilient Health Systems in Asia
  • Strategies for improving resilience in health infrastructure and enhancing health system responsiveness 

  • Policy and funding mechanisms

  • Emerging trends of investments on climate solutions in Asia, highlighting investment opportunities related to the health sector


2024 APAC Health and Life Sciences Summit Spotlight Indonesia
Indonesia, November | Agenda
Continue to be updated
Speakers
Carrie LIU
Lead, Health and Healthcare, World Economic Forum
Chang LIU
Founder & CEO, ASK Health Asia; Adjunct Associate Professor, Chinese University of Hong Kong
Louise HO Xin Qian
Assistant Vice President (Healthcare), Singapore Economic Development Board’s (EDB)
Paul HULEATT
Counsellor (Health), Australian High Commission, Singapore; Regional Advisor - Indo-Pacific Regulatory Strengthening Program (RSP); Australian Therapeutic Goods Administration (TGA)
Siddhartha BHATTACHARYA
Secretary General, Healthcare Federation of India (NATHEALTH)
Lin SHI
Policy Director, China Office, the Pharmaceutical Research and Manufacturers of America (PhRMA)
Snehal PATEL
Co-founder of aEQ and the Managing Director of Saena Partners
Joji SUGAWARA
Vice President, Health and Global Policy Institute (HGPI)
Siyuan CHEN
VP, General Manager of Bristol Myers Squibb for China & Asia Cluster
Hsien-Hsien LEI
CEO, The American Chamber of Commerce in Singapore (AmCham Singapore); Adjunct Associate Professor, Saw Swee Hock School of Public Health
Muhammed Anis Bin Abd Wahab
Head of Department, Quality Assurance, ProtectHealth Corporation Sdn. Bhd, established under the Ministry of Health Malaysia
Omolara ADETUNJI
Vice President, Global Regulatory Affairs, Asia Pacific Region, Eli Lilly and Company
Subramanyam YADAVALLI
CEO, Apollo Hospitals
Michelle TAN
General Manager, Southeast Asia, BeiGene
Raven LIN
Co-founder & CEO, Pilatus Biosciences Inc
Han XIA
CEO and Founder, HugoBiotech
Kah Yean NEO
Senior Director, Agency for Science, Technology and Research, A*Star
Hwee Ching ANG
Deputy Chief Executive Officer, Experimental Drug Development Centre (EDDC)
Alessandro FALCONE
Regional Head, JLABS Singapore
Vijay KARWAL
Managing Director, CBC Group
Ankur MUTREJA
Director of Strategy, Partnerships and Communications, PATH
Jonas KARLSTRÖM
Associate Professor, Core Lead, Innovation in Global Health, SingHealth Duke-NUS Global Health Institute
Janice JIN
President, GenScript Asia Pacific
Raymond NG
Senior Director, Strategic Innovation & Business Development, ATLATL Scientific
Kate QI
Founder & CEO, SG Diagnostics
Jing Ping YEO
Global Head, Project Operations & Head, Transformation, George Clinical
Giles NEWMARCH
Senior Investment Officer, lFC-International Finance Corporation (World Bank)
Yuan Lu HO
Co-lead, ASEAN Diagnostics Initiative, Vice President, Outreach & Talent Development, Diagnostics Development Hub
Sean SHI
Director & CEO, Sino-Innovax Biotec Pte Ltd
Christy MA
Chief Strategy Officer, SCG Cell Therapy
Eugene HONG
Head, Healthcare & Pharmaceutical, Institutional Banking Group, DBS Bank
Biao CHENG
GM of Incubation, Microsoft Asia-Pacific Research & Development Group
Dale HUNTINGTON
Senior Director, Health Care Systems Policy, Johnson & Johnson
Ryan MACFARLANE
Vice President, Access Partnership
Abdullahi SHERIFF
Vice President and Chair of the Public Policy Committee (PPC), Singapore Association of Pharmaceutical Industries (SAPI); Managing Director, MSD Pharma (Singapore) Pte Ltd.
Hiroaki TSUKADA
Senior Director, Global Policy and Public Affairs, Asia Pacific Lead, Pfizer
Pompy SRIDHAR
Director, India, MSD for Mothers
Jeff WEISEL
Co-founder, aEQ; Senior Strategic Advisor, Avalere Health
Ping Hei LI (Benjamin)
Founder, Heals Healthcare
Ramesh RAJENTHERAN
CEO & Founder, MiyaHealth
Stephen NG
Managing Director; Head of Southeast Asia and South Asia; Chief Executive Officer of Singapore, CICC
Kelly QIAO
Senior Principal, B Capital Group
Jiadi YU
Chief Investment Officer, International Finance Corporation (IFC)
May LO
Investment Director, abc Impact, Temasek Trust Asset Management
Mia HU
Investment Director, Boehringer Ingelheim Venture Fund Asia
Barney Yao
Executive Director – Equity Research, Chief AI Strategist, Haitong International
Alva CHEN
Therapeutic Practice Leader, Healthcare, VMS Group
Jolene OOI
Partner, Healthcare and Emerging Technology Investments, EDBI Pte Ltd
Jannie TSUEI
Partner, TVM Capital Healthcare
Fong Ming KOH
Principal, LYFE Capital
Wei Yang CHEONG
Vice Provost (Strategic Research Partnerships), Singapore Management University; Senior Adviser (Health Economics), Ministry of Health, Singapore
Jin Hoe KOH
Executive Director, Head, Capital Markets, Global Sales and Origination, SGX Group
Aaron GU
Partner, Han Kun Law Offices
Deepali KHANNA
Vice President, Asia, The Rockefeller Foundation
Yoshihiro KAWAI
Chairman, Global Asia Insurance Partnership (GAIP); Chairman, South East Asia Disaster Risk Insurance Facility (SEADRIF); Chairman, OECD lPPC; Advisor, Commissioner JFSA; Member, International Advisory Council, China National Financial Regulatory Administration; Professor, Tokyo University
Vera SIESJÖ
Senior One Health Scientist, Asia Infrastructure Investment Bank (AIIB)
Jean-Gaetan GUILLEMAUD
Vice President Corporate Affairs, Zuellig Pharma
Coco LIU
ESG and Sustainability Lead, Philips Greater China
Wan Cheng CHOW
Group Director, Academic Medicine, SingHealth HQ Vice Dean, Office of Academic Medicine, Duke-NUS School of Medicine Senior Consultant, Department of Gastroenterology and Hepatology, Singapore General Hospital
Karen WU
Regional Lead of APAC Supply Chain, Roche Singapore
Akhil KHURANA
Associate Director, Centre for lmpact lnvesting and Practices (an ecosystem entity of Temasek Trust)
Marc A. VAN DER LINDEN
Counselor for Health, Welfare and Sport, Embassy of the Kingdom of the Netherlands (Beijing)
Kailash RAGHUWANSHI
Director, Strategic Initiatives, Landcent Group
Renzo R. GUINTO
Associate Professor, Global and Planetary Health, SingHealth Duke-NUS Global Health Institute, Duke-NUS Medical School, Singapore
Peng ZHONG
Director, Social Innovation, Bayer Foundation
Jeannette ICKOVICS
Samuel and Liselotte Herman Professor of Social and Behavioral Sciences, Yale School of Public Health
Kelvin TAN
Head of Programme (Minor in Applied Ageing Studies), Singapore University of Social Sciences (SUSS)
Mengchun GONG
Professor, Guangdong Medical University; Senior Vice President and Chief Medical Officer, Digital Health China Technologies LTD.
Manprit SINGH
CTO Data and AI for Healthcare, Microsoft
Partners
Strategic Partners
In collaboration with World Economic Forum
Supporting Partners
Contact Us
For speaking opportunities and ticket purchase, please contact Jessica Li
For sponsorship opportunities, please contact Tina Ja
Media
Registration.
Join us at the 2024 APAC Health and Life Sciences Summit.
For more information, please contact Jessica Li at jessica.li@askhealthasia.com
2024 APAC Health And Life Sciences Summit - Partnering and Innovating for Equity and Access